Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8527919 | Clinical Therapeutics | 2018 | 9 Pages |
Abstract
In these healthy Chinese subjects, carriers of CYP2C19 loss-of-function allele(s) had significantly reduced exposure of CAM and decreased levels of inhibition of platelet aggregation with clopidogrel; these genotypes therefore might be a determinant for the formation of CAM and its antiplatelet effects. Study identifier: ChiCTR-OCH-14004382.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Bai-Li MS, Meng MS, Dan MS, Chao MS, Yu-Bing MS, Nyame MS, Hong-Wei PhD, Jian-Jun PhD,